
Noble E. Jarrell
Examiner (ID: 13867, Phone: (571)272-9077 , Office: P/1625 )
| Most Active Art Unit | 1699 |
| Art Unit(s) | 1624, 1622, 1625, 1699, 1609, 1629 |
| Total Applications | 1459 |
| Issued Applications | 965 |
| Pending Applications | 172 |
| Abandoned Applications | 340 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 20473130
[patent_doc_number] => 20260015349
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2026-01-15
[patent_title] => PROLYL HYDROXYLASE DOMAIN-CONTAINING PROTEIN (PHD) INHIBITORS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/704371
[patent_app_country] => US
[patent_app_date] => 2022-10-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11826
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -35
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18704371
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/704371 | PROLYL HYDROXYLASE DOMAIN-CONTAINING PROTEIN (PHD) INHIBITORS AND USES THEREOF | Oct 27, 2022 | Pending |
Array
(
[id] => 18770736
[patent_doc_number] => 20230365514
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-16
[patent_title] => MACROCYCLIC COMPOUNDS
[patent_app_type] => utility
[patent_app_number] => 17/962152
[patent_app_country] => US
[patent_app_date] => 2022-10-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 59767
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 957
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17962152
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/962152 | MACROCYCLIC COMPOUNDS | Oct 6, 2022 | Pending |
Array
(
[id] => 19641269
[patent_doc_number] => 20240415789
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-12-19
[patent_title] => CYCLOBENZAPRINE FOR TREATMENT OR PREVENTION OF SEXUAL DYSFUNCTION ASSOCIATED WITH MENTAL HEALTH CONDITIONS IN FEMALE PATIENTS
[patent_app_type] => utility
[patent_app_number] => 18/698483
[patent_app_country] => US
[patent_app_date] => 2022-10-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7945
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18698483
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/698483 | CYCLOBENZAPRINE FOR TREATMENT OR PREVENTION OF SEXUAL DYSFUNCTION ASSOCIATED WITH MENTAL HEALTH CONDITIONS IN FEMALE PATIENTS | Oct 4, 2022 | Pending |
Array
(
[id] => 19745601
[patent_doc_number] => 20250034166
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-01-30
[patent_title] => POLYCYCLIC FUSED RING DERIVATIVES AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/695384
[patent_app_country] => US
[patent_app_date] => 2022-09-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28736
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18695384
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/695384 | POLYCYCLIC FUSED RING DERIVATIVES AND USE THEREOF | Sep 25, 2022 | Pending |
Array
(
[id] => 18830990
[patent_doc_number] => 20230399515
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-12-14
[patent_title] => PHTHALOCYANINE DYE COMPOUNDS, CONJUGATES AND METHODS OF USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/934705
[patent_app_country] => US
[patent_app_date] => 2022-09-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 47310
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17934705
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/934705 | Phthalocyanine dye compounds, conjugates and methods of use thereof | Sep 22, 2022 | Issued |
Array
(
[id] => 19614826
[patent_doc_number] => 20240400506
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-12-05
[patent_title] => DIROXIMEL FUMARATE PARTICLES HAVING IMPROVED FLOW PROPERTIES AND METHODS OF MAKING SAME
[patent_app_type] => utility
[patent_app_number] => 18/692541
[patent_app_country] => US
[patent_app_date] => 2022-09-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5882
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18692541
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/692541 | DIROXIMEL FUMARATE PARTICLES HAVING IMPROVED FLOW PROPERTIES AND METHODS OF MAKING SAME | Sep 15, 2022 | Pending |
Array
(
[id] => 20173099
[patent_doc_number] => 12391832
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-08-19
[patent_title] => Color matched and bright fluorescent materials composed of small-molecule ionic lattices
[patent_app_type] => utility
[patent_app_number] => 17/942127
[patent_app_country] => US
[patent_app_date] => 2022-09-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 47
[patent_figures_cnt] => 42
[patent_no_of_words] => 9543
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 102
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17942127
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/942127 | Color matched and bright fluorescent materials composed of small-molecule ionic lattices | Sep 9, 2022 | Issued |
Array
(
[id] => 18321419
[patent_doc_number] => 20230119547
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-20
[patent_title] => DI-SUBSTITUTED PYRAZOLE COMPOUNDS FOR THE TREATMENT OF DISEASES
[patent_app_type] => utility
[patent_app_number] => 17/940640
[patent_app_country] => US
[patent_app_date] => 2022-09-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 50565
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17940640
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/940640 | DI-SUBSTITUTED PYRAZOLE COMPOUNDS FOR THE TREATMENT OF DISEASES | Sep 7, 2022 | Pending |
Array
(
[id] => 18346734
[patent_doc_number] => 20230134844
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-04
[patent_title] => BENZODIAZEPINE DERIVATIVES, COMPOSITIONS, AND METHODS FOR TREATING COGNITIVE IMPAIRMENT
[patent_app_type] => utility
[patent_app_number] => 17/902374
[patent_app_country] => US
[patent_app_date] => 2022-09-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 79759
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17902374
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/902374 | Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment | Sep 1, 2022 | Issued |
Array
(
[id] => 19464020
[patent_doc_number] => 20240317689
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-09-26
[patent_title] => POTASSIUM CHANNEL MODULATOR, COMPOSITION AND APPLICATION
[patent_app_type] => utility
[patent_app_number] => 18/570661
[patent_app_country] => US
[patent_app_date] => 2022-08-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13796
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 384
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18570661
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/570661 | POTASSIUM CHANNEL MODULATOR, COMPOSITION AND APPLICATION | Aug 25, 2022 | Pending |
Array
(
[id] => 18991421
[patent_doc_number] => 20240063390
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-02-22
[patent_title] => COVALENT ORGANIC FRAMEWORK AND ENERGY STORAGE DEVICE
[patent_app_type] => utility
[patent_app_number] => 17/888935
[patent_app_country] => US
[patent_app_date] => 2022-08-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4125
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17888935
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/888935 | COVALENT ORGANIC FRAMEWORK AND ENERGY STORAGE DEVICE | Aug 15, 2022 | Abandoned |
Array
(
[id] => 18312871
[patent_doc_number] => 20230116771
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-13
[patent_title] => MAYTANSINOID DERIVATIVES, CONJUGATES THEREOF, AND METHODS OF USE
[patent_app_type] => utility
[patent_app_number] => 17/889301
[patent_app_country] => US
[patent_app_date] => 2022-08-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 33378
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17889301
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/889301 | MAYTANSINOID DERIVATIVES, CONJUGATES THEREOF, AND METHODS OF USE | Aug 15, 2022 | Issued |
Array
(
[id] => 18034545
[patent_doc_number] => 20220378760
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-01
[patent_title] => METHOD FOR IMPROVING OR ENHANCING COGNITION
[patent_app_type] => utility
[patent_app_number] => 17/818183
[patent_app_country] => US
[patent_app_date] => 2022-08-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7141
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17818183
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/818183 | Method for improving or enhancing cognition | Aug 7, 2022 | Issued |
Array
(
[id] => 19871322
[patent_doc_number] => 12264166
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-04-01
[patent_title] => Asymmetric fused aromatic ring derivative containing sulfonyl group, hydrogen production device and optoelectronic component
[patent_app_type] => utility
[patent_app_number] => 17/864723
[patent_app_country] => US
[patent_app_date] => 2022-07-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 5302
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 78
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17864723
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/864723 | Asymmetric fused aromatic ring derivative containing sulfonyl group, hydrogen production device and optoelectronic component | Jul 13, 2022 | Issued |
Array
(
[id] => 18004953
[patent_doc_number] => 20220363719
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-17
[patent_title] => Reverse Amide-Linked Melanocortin Receptor-Specific Cyclic Peptides
[patent_app_type] => utility
[patent_app_number] => 17/812014
[patent_app_country] => US
[patent_app_date] => 2022-07-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24289
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -25
[patent_words_short_claim] => 283
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17812014
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/812014 | Reverse Amide-Linked Melanocortin Receptor-Specific Cyclic Peptides | Jul 11, 2022 | Pending |
Array
(
[id] => 18149610
[patent_doc_number] => 20230023467
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-01-26
[patent_title] => METAL PROTOPORPHYRIN FOR TREATMENT OF BK VIRUS
[patent_app_type] => utility
[patent_app_number] => 17/860872
[patent_app_country] => US
[patent_app_date] => 2022-07-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2901
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17860872
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/860872 | Metal protoporphyrin for treatment of BK virus | Jul 7, 2022 | Issued |
Array
(
[id] => 19464039
[patent_doc_number] => 20240317708
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-09-26
[patent_title] => INHIBITORS OF TRANSGLUTAMINASES
[patent_app_type] => utility
[patent_app_number] => 18/573802
[patent_app_country] => US
[patent_app_date] => 2022-06-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20822
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 490
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18573802
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/573802 | INHIBITORS OF TRANSGLUTAMINASES | Jun 29, 2022 | Pending |
Array
(
[id] => 19081198
[patent_doc_number] => 20240107999
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-04-04
[patent_title] => ANTIBACTERIAL COMPOSITION
[patent_app_type] => utility
[patent_app_number] => 18/027430
[patent_app_country] => US
[patent_app_date] => 2022-06-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5932
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18027430
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/027430 | ANTIBACTERIAL COMPOSITION | Jun 28, 2022 | Pending |
Array
(
[id] => 19430884
[patent_doc_number] => 20240299382
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-09-12
[patent_title] => COMPOUNDS AND METHODS FOR DEGRADING RCOR1, LSD1, HDAC1 AND HDAC2 IN THE COREST
[patent_app_type] => utility
[patent_app_number] => 18/572491
[patent_app_country] => US
[patent_app_date] => 2022-06-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18117
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18572491
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/572491 | COMPOUNDS AND METHODS FOR DEGRADING RCOR1, LSD1, HDAC1 AND HDAC2 IN THE COREST | Jun 26, 2022 | Pending |
Array
(
[id] => 19553992
[patent_doc_number] => 20240365784
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-11-07
[patent_title] => AZOLE COMPOUNDS FOR CONTROLLING INVERTEBRATE PESTS
[patent_app_type] => utility
[patent_app_number] => 18/572497
[patent_app_country] => US
[patent_app_date] => 2022-06-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 35678
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18572497
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/572497 | AZOLE COMPOUNDS FOR CONTROLLING INVERTEBRATE PESTS | Jun 22, 2022 | Pending |